Evolus (EOLS) Insider Trading & Ownership $6.40 +0.63 (+10.92%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$6.38 -0.03 (-0.39%) As of 08/12/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus (NASDAQ:EOLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$189KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$2.51M Get EOLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Evolus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EOLS Insider Buying and Selling by Quarter Evolus Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2025David MoatazediInsiderSell16,582$9.89$163,995.98 6/13/2025David MoatazediInsiderSell111,323$10.05$1,118,796.15 6/9/2025Albert G White IIIDirectorBuy20,000$9.45$189,000.00 5/13/2025Sandra BeaverCFOSell6,494$10.02$65,069.88 5/12/2025David MoatazediInsiderSell15,787$9.87$155,817.69 5/12/2025Rui AvelarInsiderSell3,385$9.87$33,409.95 3/27/2025David MoatazediInsiderSell6,251$12.40$77,512.40 3/18/2025Rui AvelarInsiderSell27,904$13.26$370,007.04 3/18/2025Sandra BeaverCFOSell8,996$13.26$119,286.96 3/18/2025Tomoko Yamagishi-DresslerCMOSell4,536$13.26$60,147.36 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/12/2025Karah Herdman ParschauerDirectorSell12,888$12.99$167,415.12 12/23/2024Rui AvelarInsiderSell2,252$10.85$24,434.20 12/23/2024Sandra BeaverCFOSell1,586$10.85$17,208.10 9/6/2024Sandra BeaverCFOSell3,276$14.98$49,074.48 8/30/2024Tomoko Yamagishi-DresslerCMOSell5,631$15.85$89,251.35 (Data available from 1/1/2013 forward) EOLS Insider Trading Activity - Frequently Asked Questions Who is on Evolus' Insider Roster? The list of insiders at Evolus includes Albert G White III, Alphaeon 1 Llc, David Moatazedi, David N Gill, Karah Herdman Parschauer, Medytox Inc., Robert Hayman, Rui Avelar, Sandra Beaver, Tomoko Yamagishi-Dressler, and Vikram Malik. Learn more on insiders at EOLS. What percentage of Evolus stock is owned by insiders? 6.10% of Evolus stock is owned by insiders. Learn more on EOLS's insider holdings. Which Evolus insiders have been buying company stock? The following insiders have purchased EOLS shares in the last 24 months: Albert G White III ($189,000.00), and Vikram Malik ($1,296,505.47). How much insider buying is happening at Evolus? Insiders have purchased a total of 194,967 EOLS shares in the last 24 months for a total of $1,485,505.47 bought. Which Evolus insiders have been selling company stock? The following insiders have sold EOLS shares in the last 24 months: David Moatazedi ($4,736,358.46), David N Gill ($46,338.96), Karah Herdman Parschauer ($324,188.46), Medytox Inc. ($12,679,972.50), Rui Avelar ($834,791.92), Sandra Beaver ($415,059.50), Tomoko Yamagishi-Dressler ($149,398.71), and Vikram Malik ($97,200.00). How much insider selling is happening at Evolus? Insiders have sold a total of 2,251,455 Evolus shares in the last 24 months for a total of $19,283,308.51 sold. Evolus Key ExecutivesMr. David Moatazedi (Age 46)President, CEO & Director Compensation: $1.75M4 recent tradesMs. Sandra Beaver (Age 46)Chief Financial Officer Compensation: $740.15k2 recent tradesDr. Rui Avelar C.CFP (Age 62)Dip.SportMed, M.D., Chief Medical Officer and Head of Research & Development Compensation: $823.19kMr. Nareg SagherianHead of Global Investor Relations & Corporate CommunicationsMr. Jeffrey J. PlumerGeneral CounselMr. Kurt KnabVice President of SalesMs. Tomoko Yamagishi-DresslerChief Marketing Officer1 recent tradesMs. Jessica NovakSenior Vice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies TVTX Insider Ownership BHVN Insider Ownership AUPH Insider Ownership SDGR Insider Ownership JANX Insider Ownership ETNB Insider Ownership EWTX Insider Ownership WVE Insider Ownership ABCL Insider Ownership HROW Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:EOLS) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access